Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Celance 50microgram tablets (Eli Lilly & Co Ltd) 100 tablet 10 x 10 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (PI) (Dowelhurst Ltd) 30 tablet 3 x 10 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (PI) (Dowelhurst Ltd) 100 tablet 10 x 10 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (IVAX Pharmaceuticals UK Ltd) 100 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (A A H Pharmaceuticals Ltd) 100 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (Galen Ltd) 63 capsule 3 x 21 capsules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (Zentiva Pharma UK Ltd) 63 capsule 3 x 21 capsules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (Teva UK Ltd) 100 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (Focus Pharmaceuticals Ltd) 63 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (Kent Pharma (UK) Ltd) 63 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (PI) (Waymade Ltd) 100 tablet 10 x 10 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (Sandoz Ltd) 100 tablet 10 x 10 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (Sigma Pharmaceuticals Plc) 63 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (A A H Pharmaceuticals Ltd) 63 capsule 3 x 21 capsules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Normax capsules (Celltech Pharmaceuticals Ltd) 63 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Celance 50microgram tablets (PI) (Dowelhurst Ltd) 30 tablet 3 x 10 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Capsuvac capsules (Galen Ltd) 63 capsule 3 x 21 capsules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (Unichem Plc) 100 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (Sigma Pharmaceuticals Plc) 100 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Co-danthrusate 50mg/60mg capsules (Waymade Healthcare Plc) 63 capsule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pergolide 50microgram tablets (Phoenix Healthcare Distribution Ltd) 100 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 2,500units/0.5ml solution for injection vials |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 5,000units/1ml solution for injection vials |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 10,000units/2ml solution for injection vials |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 7.35% solution for injection 10ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Progesterone 25mg/1.119ml solution for injection vials |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (Unichem Plc) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules 10 ampoule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules 10 ampoule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (The Boots Company) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules (Unichem Plc) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules 10 ampoule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (Rosemont Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 2,500units/0.5ml solution for injection vials 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 2,500units/0.5ml solution for injection vials (Medeus Pharma) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Physeptone 35mg/3.5ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 5,000units/1ml solution for injection vials (Medeus Pharma) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules (Unichem Plc) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules (Unichem Plc) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 5,000units/1ml solution for injection vials 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 10,000units/2ml solution for injection vials (Medeus Pharma) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Lubion 25mg/1.119ml solution for injection vials (IBSA Pharma Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules 10 ampoule |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 10,000units/2ml solution for injection vials 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Progesterone 25mg/1.119ml solution for injection vials 7 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Physeptone 35mg/3.5ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 2,500units/0.5ml solution for injection vials (Medeus Pharma) 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (The Boots Company) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 5,000units/1ml solution for injection vials (Medeus Pharma) 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 10,000units/2ml solution for injection vials (Medeus Pharma) 1 vial |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 10ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Lubion 25mg/1.119ml solution for injection vials (IBSA Pharma Ltd) 7 vial |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (C P Pharmaceuticals Ltd) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 735mg/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 15.4mg/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Methadone 35mg/3.5ml solution for injection ampoules (Rosemont Pharmaceuticals Ltd) 10 ampoule 10 x 3.5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Pethidine 50mg/5ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 5ml ampoules |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely venlafaxine 50 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Venlafaxine 50mg tablets (PI) (Dowelhurst Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Venlafaxine 50mg tablets 42 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Efexor 50mg tablets (Wyeth Laboratories) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Efexor 50mg tablets (PI) (Dowelhurst Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Efexor 50mg tablets (PI) (Dowelhurst Ltd) 42 tablet 2 x 21 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Efexor 50mg tablets (Wyeth Laboratories) 42 tablet 2 x 21 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Venlafaxine 50mg tablets (PI) (Dowelhurst Ltd) 42 tablet 2 x 21 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) 10micrograms/1ml vaccine suspension for injection pre-filled syringes |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daclatasvir 30mg tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daclatasvir 60mg tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) 10micrograms/1ml vaccine suspension for injection pre-filled syringes 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daclatasvir 60mg tablets 28 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daclatasvir 30mg tablets 28 tablet |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
HBVAXPRO 10micrograms/1ml vaccine suspension for injection pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
HBVAXPRO 10micrograms/1ml vaccine suspension for injection pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Triclosan 1% liquid |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Skinsan 1% skin cleanser (Ecolab Healthcare Division) |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|
Triclosan 1% liquid 500 ml |
VMP non-availability indicator |
True |
Not available |
Inferred relationship |
Existential restriction modifier |
|